Analyst
Leerink Partners
Equibles does not estimate personal net worth.
Puneet Souda is recorded as Analyst at Leerink Partners. Puneet Souda has spoken on 13 earnings calls and 1 other investor event across 8 companies, most recently for Repligen Corp on July 28, 2026. Those appearances were for Bruker Corp (BRKR), Guardant Health, Inc. (GH), 10x Genomics, Inc. (TXG), Repligen Corp (RGEN), Veracyte, Inc. (VCYT) and 3 other companies. The companies whose calls Puneet Souda spoke on are classified in the Healthcare sector.
“How are products, you know, what products are gaining traction there in a fairly competitive market? Maybe just elaborate a bit on that. And then on the onshoring piece, Olivier, how are you thinking about the, you know, timing and magnitude of that?”
“So, first one, actually, maybe for Gerald. On the margin side, could you elaborate a little bit on the second half ramp? It is, I mean, first of all, come routes on the quarter, but just it is steep still.”
“Maybe Mark, Rebecca, Rebecca, I just wanted to understand on the no-result rate and the improvement that you're getting from Transcriptome, could you talk about what's the ceiling there?”
“Hi, good afternoon, and thank you for taking my questions, both on S.H.I.E.L.D. and they're related.”
Leerink Partners
Analyst
Source not stated
BRKR
Medical Devices · Healthcare
Diagnostics & Research · Healthcare
RGEN
Medical Instruments & Supplies · Healthcare
VCYT
Diagnostics & Research · Healthcare
MASS
Medical Devices · Healthcare
OABI
Biotechnology · Healthcare
